CapsoVision, Inc. is a Silicon Valley-based medical device manufacturer focused on developing cutting-edge solutions in the field of capsule endoscopy (CE). Founded in 2005, the company has positioned itself as an innovator in the healthcare industry, with a commitment to empowering physicians, streamlining clinical operations, and enhancing patient experience. Their flagship product, CapsoCam Plus®, offers a 360° field of view and does not require any capital equipment, setting it apart from traditional CE systems. In addition, the company provides a state-of-the-art CapsoCloud® cloud-based software for efficient image review and analysis, further demonstrating their dedication to technological advancement in the medical field. CapsoVision's recent Venture Round investment at 01 January 2022, which was led by Taiwan Global Angels, signifies a strong vote of confidence from the investment community. This financial support is indicative of the belief in CapsoVision's innovative approach and the potential impact of their products on the healthcare industry. As the company continues to make strides in their Health Care sector, the recent investment is expected to further propel their growth and solidify their position as a leader in the development of advanced medical solutions.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Venture Round | Unknown | 1 | 01 Jan 2022 | |
Venture Round | $64.83M | - | 26 Nov 2019 | |
Venture Round | $8.00M | - | 05 Jan 2018 | |
Venture Round | $4.60M | - | 25 Apr 2016 | |
Venture Round | $15.90M | - | 21 Feb 2014 |
No recent news or press coverage available for CapsoVision, Inc..